INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)
$1.77 0.03 (1.7241%)
Analysed INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) News Sources
Number of Shares and Voting Rights of Innate Pharma as of April 9, 2026
13-04-2026
yahoo.com
Innate Pharma to Present MATISSE Phase 2 Interim Results of IPH5201 in Clinical Trials Plenary Session at AACR 2026
17-04-2026
yahoo.com
Innate Pharma to Participate in the D. Boral Capital Global Conference
23-04-2026
yahoo.com
Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight
27-04-2026
yahoo.com
Innate Pharma Announces Conference Call and Webcast for Q1 2026 Business Update
06-05-2026
yahoo.com
Number of Shares and Voting Rights of Innate Pharma as of April 16, 2026
12-05-2026
yahoo.com
Innate Pharma Reports First Quarter 2026 Business Update and Financial Results
13-05-2026
yahoo.com
Innate Pharma Q1 Earnings Call Highlights
13-05-2026
marketbeat.com
Innate Pharma to participate in the Jefferies Global Healthcare Conference
19-05-2026
yahoo.com
Outcome of Innate Pharma’s 2026 Annual General Meeting
22-05-2026
yahoo.com
What is the current price of INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)?
The current price of INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) is $1.77.
INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) absolute price change since previous trading day?
The absolute price change of INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) since the previous trading day is $0.03.
INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) percentage price change since previous trading day?
The percentage price change of INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) since the previous trading day is 1.7241%.
What is the most recent average sentiment score for INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)?
The most recent average sentiment score for INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) is 62 out of 100.
What is the most recent average sentiment for INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)?
The most recent sentiment for INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ) is .
SEC-8K** Filing Available For INNATE PHARMA SA-SPONS ADR (IPHA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.